ID

22000

Beschrijving

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00452881

Link

https://clinicaltrials.gov/show/NCT00452881

Trefwoorden

  1. 14-05-17 14-05-17 -
Geüploaded op

14 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lung Cancer NCT00452881

Eligibility Lung Cancer NCT00452881

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologic diagnosis of non-small cell lung cancer.
Beschrijving

nsclc

Datatype

boolean

Alias
UMLS CUI [1]
C0007131
2. presence of pathological stage ib, ii or iiia, according to the american joint committee on cancer (ajcc).
Beschrijving

nsclc ajcc stage

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0441915
3. completely resected tumor at ncc hospital.
Beschrijving

complete nsclc tumor resection

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0015250
4. no prior tumor therapy (radiotherapy, chemotherapy, immunotherapy, or any other type of tumor therapy).
Beschrijving

prior tumor therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C1514463
5. performance status of 0-1 on ecog scale.
Beschrijving

ecog

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
6. at least 18 years old
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
7. patient compliance that allows adequate follow-up.
Beschrijving

follow-up compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C1321605
8. adequate organ function including the following:adequate hematologic function: wbc count ≥ 4,000/ul, absolute neutrophil count (anc) ≥ 1,500/ul, platelet count ≥ 100,000/ul, and hemoglobin ³ 10 gm/dl.adequate hepatic function: bilirubin ≤ 1.5 x unl, alt or ast ≤ 2.5 x unl.adequate renal function: creatinine ≤ 1.5mg/dl.
Beschrijving

hematologic, hepatic, renal function

Datatype

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0948762
UMLS CUI [1,3]
C0005821
UMLS CUI [1,4]
C0019046
UMLS CUI [2,1]
C0232741
UMLS CUI [2,2]
C1278039
UMLS CUI [2,3]
C0201899
UMLS CUI [2,4]
C0201836
UMLS CUI [3,1]
C0232804
UMLS CUI [3,2]
C0201976
9. signed informed consent from patient or legal representative.
Beschrijving

informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
10. patients with reproductive potential must use an approved contraceptive method during and for 3 months after the study. females with childbearing potential must have a negative urine hcg test within 7 days prior to study enrollment.
Beschrijving

effective contraception, pregnancy test

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C0032976
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. concurrent administration of any other tumor therapy, including radiotherapy, chemotherapy, immunotherapy.
Beschrijving

concurrent tumor therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
2. active uncontrolled infection.
Beschrijving

uncontrolled infection

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
3. serious concomitant disorders that would compromise the safety of patient or compromise the patient's ability to tolerate therapy.
Beschrijving

comorbidities

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
4. second primary malignancy.
Beschrijving

second primary malignancy

Datatype

boolean

Alias
UMLS CUI [1]
C0751623
5. significant neurological or mental disorder.
Beschrijving

neurological or mental disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0004936
6. pregnant or nursing.
Beschrijving

pregnancy, breast feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
7. mi within preceding 6 months or symptomatic heart disease including unstable angina, congestive heart failure, or uncontrolled arrhythmia
Beschrijving

heart diseases

Datatype

boolean

Alias
UMLS CUI [1]
C0018799

Similar models

Eligibility Lung Cancer NCT00452881

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
nsclc
Item
1. histologic diagnosis of non-small cell lung cancer.
boolean
C0007131 (UMLS CUI [1])
nsclc ajcc stage
Item
2. presence of pathological stage ib, ii or iiia, according to the american joint committee on cancer (ajcc).
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0441915 (UMLS CUI [1,3])
complete nsclc tumor resection
Item
3. completely resected tumor at ncc hospital.
boolean
C0007131 (UMLS CUI [1,1])
C0015250 (UMLS CUI [1,2])
prior tumor therapy
Item
4. no prior tumor therapy (radiotherapy, chemotherapy, immunotherapy, or any other type of tumor therapy).
boolean
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
ecog
Item
5. performance status of 0-1 on ecog scale.
boolean
C1520224 (UMLS CUI [1])
age
Item
6. at least 18 years old
boolean
C0001779 (UMLS CUI [1])
follow-up compliance
Item
7. patient compliance that allows adequate follow-up.
boolean
C3274571 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
hematologic, hepatic, renal function
Item
8. adequate organ function including the following:adequate hematologic function: wbc count ≥ 4,000/ul, absolute neutrophil count (anc) ≥ 1,500/ul, platelet count ≥ 100,000/ul, and hemoglobin ³ 10 gm/dl.adequate hepatic function: bilirubin ≤ 1.5 x unl, alt or ast ≤ 2.5 x unl.adequate renal function: creatinine ≤ 1.5mg/dl.
boolean
C0221130 (UMLS CUI [1,1])
C0948762 (UMLS CUI [1,2])
C0005821 (UMLS CUI [1,3])
C0019046 (UMLS CUI [1,4])
C0232741 (UMLS CUI [2,1])
C1278039 (UMLS CUI [2,2])
C0201899 (UMLS CUI [2,3])
C0201836 (UMLS CUI [2,4])
C0232804 (UMLS CUI [3,1])
C0201976 (UMLS CUI [3,2])
informed consent
Item
9. signed informed consent from patient or legal representative.
boolean
C0021430 (UMLS CUI [1])
effective contraception, pregnancy test
Item
10. patients with reproductive potential must use an approved contraceptive method during and for 3 months after the study. females with childbearing potential must have a negative urine hcg test within 7 days prior to study enrollment.
boolean
C0700589 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
concurrent tumor therapy
Item
1. concurrent administration of any other tumor therapy, including radiotherapy, chemotherapy, immunotherapy.
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
uncontrolled infection
Item
2. active uncontrolled infection.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
comorbidities
Item
3. serious concomitant disorders that would compromise the safety of patient or compromise the patient's ability to tolerate therapy.
boolean
C0009488 (UMLS CUI [1])
second primary malignancy
Item
4. second primary malignancy.
boolean
C0751623 (UMLS CUI [1])
neurological or mental disorder
Item
5. significant neurological or mental disorder.
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
pregnancy, breast feeding
Item
6. pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
heart diseases
Item
7. mi within preceding 6 months or symptomatic heart disease including unstable angina, congestive heart failure, or uncontrolled arrhythmia
boolean
C0018799 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial